<?xml version="1.0" encoding="UTF-8"?>
<p>Vaccine development against the Zika virus began in earnest in late 2015 following the reports of microcephaly in fetuses and infants in Brazil. Of note, the first demonstration of immunoprotection was as part of a 1953 study to define the ultrastructural characteristics of Zika virus, that found intramuscular vaccination of mice with infectious viral filtrates protected against cerebral infection [
 <xref rid="B36-tropicalmed-04-00104" ref-type="bibr">36</xref>].
</p>
